Chulani Karunatilake

Director Técnico/Científico/I+D en WEREWOLF THERAPEUTICS, INC. .

Fortuna: - $ al 30/04/2024

65 años

Health Technology

Consumer Services

Cargos activos de Chulani Karunatilake

Empresas	Cargo	Inicio	Fin
WEREWOLF THERAPEUTICS, INC.	Director Técnico/Científico/I+D	15/06/2021	-

Empresas	Cargo	Inicio	Fin
NEKTAR THERAPEUTICS	Corporate Officer/Principal	-	-
Maverick Therapeutics, Inc. Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA.	Corporate Officer/Principal	-	-

University of Illinois	Doctorate Degree
University of Colombo	Undergraduate Degree

Internacional

Estados Unidos	5
Sri Lanka	2

Operativa

Corporate Officer/Principal	2
Chief Tech/Sci/R&D Officer	1
Doctorate Degree	1

Sectorial

Health Technology	4
Consumer Services	3

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	2
WEREWOLF THERAPEUTICS, INC.	Health Technology
NEKTAR THERAPEUTICS	Health Technology

Empresas privadas	1
Maverick Therapeutics, Inc. Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA.	Health Technology

Empresas privadas

Health Technology